Related Experiment Videos
Therapeutic approaches to prion diseases
Giacomina Rossi1, Mario Salmona, Gianluigi Forloni
1Division of Neuropathology and Neurology, Instituto Nazionale Neurologico Carlo Besta, Via Celoria 11, 20133 Milano, Italy.
Clinics in Laboratory Medicine
|May 8, 2003
Summary
Prion diseases have diverse origins and spread through neural pathways. Effective treatments must target the preclinical stage, as current therapies are limited and require early intervention.
Area of Science:
- Neuroscience
- Infectious Diseases
- Biochemistry
Background:
- Prion diseases present as sporadic, genetic, or acquired forms, with distinct neuroinvasion pathways.
- Peripheral prion exposure involves lymphoid organs and neural pathways (vagus and splanchnic nerves) before central nervous system (CNS) involvement.
- In genetic and sporadic forms, PrPSc (prion protein scrapie) formation is primarily confined to the CNS.
Purpose of the Study:
- To review the pathogenesis of prion diseases and identify potential therapeutic strategies.
- To highlight the critical need for interventions during the preclinical stage of prion disease.
- To explore various mechanisms for inhibiting PrPSc formation and discuss current therapeutic limitations.
Main Methods:
- Review of longitudinal studies on experimental scrapie to understand neuropathological changes.
- Analysis of known mechanisms for inhibiting PrPSc formation.
- Evaluation of the efficacy of compounds in preclinical and in vitro models.
Main Results:
- Neuropathological changes in prion diseases correlate with PrPSc deposits and precede symptom onset.
- Current therapeutic interventions are most effective when administered very early post-infection, often before clinical manifestation.
- Various compounds show in vitro/in vivo efficacy through different mechanisms, but none are curative in later stages.
Conclusions:
- Effective prion disease management requires targeting preclinical stages, necessitating the development of diagnostic tools.
- A combination of therapeutic strategies and compounds with diverse mechanisms is likely necessary for treatment.
- Future research should focus on preclinical diagnostics, immunization for peripherally acquired forms, and novel compounds for CNS-targeted therapies.